×
AxoGen Long Term Debt 2010-2024 | AXGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AxoGen long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
AxoGen Long Term Debt 2010-2024 | AXGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AxoGen long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$212.6B
Intuitive Surgical (ISRG)
$186.7B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.5B
Edwards Lifesciences (EW)
$38.8B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$26.9B
Waters (WAT)
$22.9B
SONOVA HOLDING (SONVY)
$22B
STERIS (STE)
$21.3B
Hologic (HOLX)
$18.4B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Sysmex ADR (SSMXY)
$12.4B
Globus Medical (GMED)
$11.1B
Teleflex (TFX)
$9.2B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.6B
Glaukos (GKOS)
$7.7B
PROCEPT BioRobotics (PRCT)
$5B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
Veracyte (VCYT)
$2.9B
LivaNova (LIVN)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.2B
Integra LifeSciences Holdings (IART)
$2B
RxSight (RXST)
$1.9B
Alphatec Holdings (ATEC)
$1.3B